Gladwin, Mark, MD: Clinical Trials

13 trials sponsored by Gladwin, Mark, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 2 withdrawn. 9 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 5, Terminated 3, Withdrawn 1
Phase 14Completed 2, Terminated 1, Withdrawn 1

Follow Gladwin, Mark, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension
Nitrates, Chlorhexidine Gluconate Mouthwash, Placebo Mouthwash - Pulmonary Hypertension, Heart Failure With Normal Ejection Fraction
Phase 1WithdrawnGladwin, Mark, MD2022-12-012022-07-07
Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age
Placebos, 20mg sodium nitrite tid - Aging, Sedentary Lifestyle
Phase 2CompletedGladwin, Mark, MD642021-04-232024-10-10
Oral Nitrite Trial for Hypertension and Metabolic Syndrome
14 Nitrogen (N) Sodium Nitrite, Placebo - Metabolic Syndrome, Hypertension
Phase 2WithdrawnGladwin, Mark, MD2020-10-012021-04-19
Oral CXA-10 in Pulmonary Arterial Hypertension
CXA-10 - Pulmonary Arterial Hypertension
Phase 2TerminatedGladwin, Mark, MD12019-10-312022-01-12
Transfusion of Biotin-Labeled Red Blood Cells
Biotin-Labeled Red Blood Cells - Healthy Volunteers
Phase 2TerminatedGladwin, Mark, MD62019-09-162022-04-21
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction
15N Nitrate, 14N Nitrate - Pulmonary; Hypertension, Heart Failure
Phase 1CompletedGladwin, Mark, MD772017-08-282022-03-22
Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction
sodium nitrite, Control - Heart Failure
Phase 2CompletedGladwin, Mark, MD152017-04-032020-01-22
Oral Nitrite for Older Heart Failure Patients
14 N Sodium Nitrite - Heart Failure
Phase 2CompletedGladwin, Mark, MD212016-01-082018-09-18
The Effects of NOx and Conjugated Linoleic Acid on Asthmatics
Conjugated Linolenic Acid, Sodium Nitrite, Sodium Nitrate - Asthma
Phase 2CompletedGladwin, Mark, MD62015-09-012021-04-27
Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults
15Nitrogen(15N)-labeled sodium nitrite, 15Nitrogen(15N)-labeled sodium nitrate - Focus of Study of Healthy Adults
Phase 1CompletedGladwin, Mark, MD112012-10-012018-09-04
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
14Nitrogen Sodium Nitrite - Metabolic Syndrome, Hypertension
Phase 2CompletedGladwin, Mark, MD202012-10-012019-04-16
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Optical Coherence Tomography, Acetylcholine, Brachial Artery Flow Mediated Dilation - Cardiac Allograft Vasculopathy, Antibody Mediated Rejection
Phase 1TerminatedGladwin, Mark, MD122012-09-012017-09-06
Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Sodium Nitrite - Primary Graft Dysfunction
Phase 2TerminatedGladwin, Mark, MD32011-10-012018-08-01

Conditions studied

Heart Failure (3)  ·  Hypertension (2)  ·  Hypertension, Pulmonary (2)  ·  Metabolic Syndrome (2)  ·  Asthma (1)  ·  Frailty (1)  ·  Obesity (1)  ·  Primary Graft Dysfunction (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Pulmonary Heart Disease (1)  ·  Sedentary Behavior (1)

Interventions

Sodium Nitrite (6)  ·  Acetylcholine (1)  ·  CXA-10 (1)  ·  Nitrates (1)  ·  Nitrites (1)  ·  Tomography, Optical Coherence (1)  ·  eleostearic acid (1)  ·  sodium nitrate (1)

Countries

United States (13)

Top investigators

Kara S Hughan, MD (3)  ·  Mark Gladwin, MD (3)  ·  Alison Morris, MD, MS (1)  ·  Bret Goodpaster, PhD (1)  ·  Catalin Toma, MD (1)  ·  Daniel E Forman, MD (1)  ·  Daniel Forman, MD (1)  ·  Darrell Triulzi, MD (1)  ·  Marc Simon, MD (1)  ·  Mark T Gladwin, MD (1)  ·  Matthew Morrell, MD (1)  ·  Sally E Wenzel, MD (1)

Results publications

PMID 28739973, PMID 32755471, PMID 41691463

NIH funding

P01HL103455 (3), R01AG058883 (1), R01HL098032 (1), R56AG051637 (1)